These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8521881)

  • 1. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure.
    Bristow MR; Gilbert EM
    Eur Heart J; 1995 Jul; 16 Suppl F():20-31. PubMed ID: 8521881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of heart failure: what--when--how?].
    Blömer H
    Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435
    [No Abstract]   [Full Text] [Related]  

  • 4. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers in heart failure.
    Cohn JN
    Eur Heart J; 1998 Jun; 19 Suppl F():F52-5. PubMed ID: 9651736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
    Sigmund M; Reineke T
    Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blocker therapy in heart failure.
    Carson P
    Cardiol Clin; 2001 May; 19(2):267-78, vi. PubMed ID: 11407109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Cavallo MJ; Child MJ; Spinale FG
    J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positive inotropic substances. Possible use in heart failure in the aged].
    Michel D
    Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of heart failure. I. Definition, pathophysiology, therapy of acute heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):30-4. PubMed ID: 9280746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M; Pignataro C; Fraticelli A; Mebazaa A
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilating beta-blockers in heart failure.
    Raftery EB
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The place of cardiac glycosides in the treatment of chronic heart failure. Part III. The DIG trial].
    Sidorenko BA; Preobrazhenskiĭ DV; Sharoshina IA; Batyraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(6):61-70. PubMed ID: 16007036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.